Extended Data Fig. 10: Efficacy of Selinexor combined with AKT inhibition on leukemia initiating cells. | Nature Cancer

Extended Data Fig. 10: Efficacy of Selinexor combined with AKT inhibition on leukemia initiating cells.

From: P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Extended Data Fig. 10

a) Leukemic burden of mice (n = 3 biologically independent mice per group) prior to sorting and engraftment for extreme limiting dilution assay. P values calculated using unpaired two-sided Welch’s test; data are presented as mean + /-s.d. b) FACS plots depicting gating strategy to isolate dsRed+ MLL-AF9 cells prior to engraftment for extreme limiting-dilution assay. c) Kaplan–Meier curves showing overall survival of secondary recipient mice (n = 5 biologically independent mice) from each group in limiting dilution assay for determining LIC frequency. Statistical significance determined by log-rank (Mantel-Cox) test. n.s, not significant.

Source data

Back to article page